-+ 0.00%
-+ 0.00%
-+ 0.00%

Structure Therapeutics Reports Positive Phase 2b Results for Oral GLP-1 Agonist Aleniglipron

路透·12/08/2025 13:01:14

登錄查看新聞詳情